
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression
Eilam Yeini, Paula Ofek, Sabina Pozzi, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 58
Eilam Yeini, Paula Ofek, Sabina Pozzi, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 58
Showing 1-25 of 58 citing articles:
Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy
Fatima Khan, Lizhi Pang, Madeline Dunterman, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 1
Open Access | Times Cited: 192
Fatima Khan, Lizhi Pang, Madeline Dunterman, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 1
Open Access | Times Cited: 192
Microengineered perfusable 3D-bioprinted glioblastoma model for in vivo mimicry of tumor microenvironment
Lena Neufeld, Eilam Yeini, Noa Reisman, et al.
Science Advances (2021) Vol. 7, Iss. 34
Open Access | Times Cited: 138
Lena Neufeld, Eilam Yeini, Noa Reisman, et al.
Science Advances (2021) Vol. 7, Iss. 34
Open Access | Times Cited: 138
3D bioprinted cancer models: from basic biology to drug development
Lena Neufeld, Eilam Yeini, Sabina Pozzi, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 12, pp. 679-692
Closed Access | Times Cited: 76
Lena Neufeld, Eilam Yeini, Sabina Pozzi, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 12, pp. 679-692
Closed Access | Times Cited: 76
Glioblastoma heterogeneity at single cell resolution
David Eisenbarth, Yanru Wang
Oncogene (2023) Vol. 42, Iss. 27, pp. 2155-2165
Open Access | Times Cited: 74
David Eisenbarth, Yanru Wang
Oncogene (2023) Vol. 42, Iss. 27, pp. 2155-2165
Open Access | Times Cited: 74
Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma
Alessandra De Leo, Alessio Ugolini, Xiaoqing Yu, et al.
Immunity (2024) Vol. 57, Iss. 5, pp. 1105-1123.e8
Closed Access | Times Cited: 63
Alessandra De Leo, Alessio Ugolini, Xiaoqing Yu, et al.
Immunity (2024) Vol. 57, Iss. 5, pp. 1105-1123.e8
Closed Access | Times Cited: 63
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 62
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 62
Targeting Microglial Metabolic Rewiring Synergizes with Immune-Checkpoint Blockade Therapy for Glioblastoma
Zengpanpan Ye, Xiaolin Ai, Kailin Yang, et al.
Cancer Discovery (2023) Vol. 13, Iss. 4, pp. 974-1001
Open Access | Times Cited: 47
Zengpanpan Ye, Xiaolin Ai, Kailin Yang, et al.
Cancer Discovery (2023) Vol. 13, Iss. 4, pp. 974-1001
Open Access | Times Cited: 47
Modelling the complex nature of the tumor microenvironment: 3D tumor spheroids as an evolving tool
Daniel B. Rodrigues, Rui L. Reis, Rogério P. Pirraco
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 17
Daniel B. Rodrigues, Rui L. Reis, Rogério P. Pirraco
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 17
Rationally designed drug delivery systems for the local treatment of resected glioblastoma
Chiara Bastiancich, Alessio Malfanti, Véronique Préat, et al.
Advanced Drug Delivery Reviews (2021) Vol. 177, pp. 113951-113951
Open Access | Times Cited: 70
Chiara Bastiancich, Alessio Malfanti, Véronique Préat, et al.
Advanced Drug Delivery Reviews (2021) Vol. 177, pp. 113951-113951
Open Access | Times Cited: 70
Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma
Wenjing Xuan, Wen-Hao Hsu, Fatima Khan, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 6, pp. 770-784
Open Access | Times Cited: 66
Wenjing Xuan, Wen-Hao Hsu, Fatima Khan, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 6, pp. 770-784
Open Access | Times Cited: 66
Tumor-Associated Macrophages in Gliomas—Basic Insights and Treatment Opportunities
Johannes K. Andersen, Hrvoje Miletić, Jubayer A. Hossain
Cancers (2022) Vol. 14, Iss. 5, pp. 1319-1319
Open Access | Times Cited: 64
Johannes K. Andersen, Hrvoje Miletić, Jubayer A. Hossain
Cancers (2022) Vol. 14, Iss. 5, pp. 1319-1319
Open Access | Times Cited: 64
From cells to organoids: The evolution of blood-brain barrier technology for modelling drug delivery in brain cancer
Estrella Gonzales‐Aloy, Aria Ahmed-Cox, Maria Tsoli, et al.
Advanced Drug Delivery Reviews (2023) Vol. 196, pp. 114777-114777
Closed Access | Times Cited: 28
Estrella Gonzales‐Aloy, Aria Ahmed-Cox, Maria Tsoli, et al.
Advanced Drug Delivery Reviews (2023) Vol. 196, pp. 114777-114777
Closed Access | Times Cited: 28
Distinct roles of TREM2 in central nervous system cancers and peripheral cancers
Jian Zhong, Xudong Xing, Yixin Gao, et al.
Cancer Cell (2024) Vol. 42, Iss. 6, pp. 968-984.e9
Closed Access | Times Cited: 12
Jian Zhong, Xudong Xing, Yixin Gao, et al.
Cancer Cell (2024) Vol. 42, Iss. 6, pp. 968-984.e9
Closed Access | Times Cited: 12
The ins and outs of microglial cells in brain health and disease
Carla Pallarés-Moratalla, Gabriele Bergers
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Carla Pallarés-Moratalla, Gabriele Bergers
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Meet me halfway: Are in vitro 3D cancer models on the way to replace in vivo models for nanomedicine development?
Sabina Pozzi, Anna Scomparin, Sahar Israeli Dangoor, et al.
Advanced Drug Delivery Reviews (2021) Vol. 175, pp. 113760-113760
Closed Access | Times Cited: 47
Sabina Pozzi, Anna Scomparin, Sahar Israeli Dangoor, et al.
Advanced Drug Delivery Reviews (2021) Vol. 175, pp. 113760-113760
Closed Access | Times Cited: 47
Macrophages/Microglia in the Glioblastoma Tumor Microenvironment
Jun Ma, Clark C. Chen, Ming Li
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5775-5775
Open Access | Times Cited: 47
Jun Ma, Clark C. Chen, Ming Li
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5775-5775
Open Access | Times Cited: 47
Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma
Lizhi Pang, Fatima Khan, Amy B. Heimberger, et al.
Trends in cancer (2022) Vol. 8, Iss. 10, pp. 839-854
Open Access | Times Cited: 37
Lizhi Pang, Fatima Khan, Amy B. Heimberger, et al.
Trends in cancer (2022) Vol. 8, Iss. 10, pp. 839-854
Open Access | Times Cited: 37
The role of P-selectin in cancer-associated thrombosis and beyond
Eilam Yeini, Ronit Satchi‐Fainaro
Thrombosis Research (2022) Vol. 213, pp. S22-S28
Closed Access | Times Cited: 34
Eilam Yeini, Ronit Satchi‐Fainaro
Thrombosis Research (2022) Vol. 213, pp. S22-S28
Closed Access | Times Cited: 34
Cancer cell intrinsic TIM-3 induces glioblastoma progression
Qing Guo, Shuai Shen, Gefei Guan, et al.
iScience (2022) Vol. 25, Iss. 11, pp. 105329-105329
Open Access | Times Cited: 29
Qing Guo, Shuai Shen, Gefei Guan, et al.
iScience (2022) Vol. 25, Iss. 11, pp. 105329-105329
Open Access | Times Cited: 29
Targeting CD24 as a novel immunotherapy for solid cancers
Yan Yang, Guangming Zhu, Li Yang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Yan Yang, Guangming Zhu, Li Yang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Preclinical Models and Technologies in Glioblastoma Research: Evolution, Current State, and Future Avenues
Hasan Slika, Ziya Karimov, Paolo Alimonti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16316-16316
Open Access | Times Cited: 20
Hasan Slika, Ziya Karimov, Paolo Alimonti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16316-16316
Open Access | Times Cited: 20
Reprogramming of tumor-associated macrophages by metabolites generated from tumor microenvironment
Seung Woo Kim, Chan Woo Kim, Young-Ah Moon, et al.
Animal Cells and Systems (2024) Vol. 28, Iss. 1, pp. 123-136
Open Access | Times Cited: 8
Seung Woo Kim, Chan Woo Kim, Young-Ah Moon, et al.
Animal Cells and Systems (2024) Vol. 28, Iss. 1, pp. 123-136
Open Access | Times Cited: 8
Pharmacological targeting of the tumor–immune symbiosis in glioblastoma
Lizhi Pang, Fatima Khan, Madeline Dunterman, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 8, pp. 686-700
Open Access | Times Cited: 24
Lizhi Pang, Fatima Khan, Madeline Dunterman, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 8, pp. 686-700
Open Access | Times Cited: 24
Microglia and Brain Macrophages as Drivers of Glioma Progression
Yuqi Zheng, Manuel B. Graeber
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15612-15612
Open Access | Times Cited: 24
Yuqi Zheng, Manuel B. Graeber
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15612-15612
Open Access | Times Cited: 24
Microglial Priming in Infections and Its Risk to Neurodegenerative Diseases
Maiara N. Lima, Maria Carolina Barbosa‐Silva, Tatiana Maron‐Gutierrez
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 20
Maiara N. Lima, Maria Carolina Barbosa‐Silva, Tatiana Maron‐Gutierrez
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 20